Topical Formulation of Noscapine, a Benzylisoquinoline Alkaloid, Ameliorates Imiquimod-Induced Psoriasis-Like Skin Lesions.
Journal
Evidence-based complementary and alternative medicine : eCAM
ISSN: 1741-427X
Titre abrégé: Evid Based Complement Alternat Med
Pays: United States
ID NLM: 101215021
Informations de publication
Date de publication:
2022
2022
Historique:
received:
06
01
2022
revised:
17
03
2022
accepted:
05
04
2022
entrez:
2
5
2022
pubmed:
3
5
2022
medline:
3
5
2022
Statut:
epublish
Résumé
Psoriasis is considered an autoimmune inflammatory disease. The disease is spread and diagnosed by the infiltration of inflammatory mediators and cells into the epidermis. Recent theoretical developments have focused on the effectiveness of noscapine (NOS) as a potential alkaloid for being used as a valuable treatment for different diseases. In the present study, psoriasis-like dermatitis was induced on the right ear pinna surface of male
Identifiants
pubmed: 35497929
doi: 10.1155/2022/3707647
pmc: PMC9054439
doi:
Types de publication
Journal Article
Langues
eng
Pagination
3707647Informations de copyright
Copyright © 2022 Fahimeh Nourbakhsh et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Pain. 2016 Nov;157(11):2536-2543
pubmed: 27437787
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Evid Based Complement Alternat Med. 2021 Mar 30;2021:6681729
pubmed: 33859710
Pharmacol Rep. 2021 Apr;73(2):443-453
pubmed: 33460006
J Immunol. 2011 Dec 1;187(11):5813-23
pubmed: 22048773
Br J Pharmacol. 2018 Feb;175(3):407-411
pubmed: 29350411
J Dermatol. 2014 Feb;41(2):135-43
pubmed: 24387343
J Exp Med. 2020 Jan 6;217(1):
pubmed: 31727781
Cancer Res. 2010 Apr 15;70(8):3259-68
pubmed: 20354190
Dermatol Reports. 2014 Sep 08;6(1):5451
pubmed: 25386329
PLoS One. 2013 Jun 25;8(6):e67078
pubmed: 23825622
Autoimmun Rev. 2016 Dec;15(12):1167-1170
pubmed: 27639838
J Ethnopharmacol. 2020 Jun 28;256:112706
pubmed: 32109547
Methods Mol Biol. 2014;1180:31-43
pubmed: 25015141
PLoS One. 2018 Feb 1;13(2):e0192010
pubmed: 29389950
Br J Dermatol. 2007 Dec;157 Suppl 2:8-13
pubmed: 18067624
Clin Dermatol. 2007 Nov-Dec;25(6):535-46
pubmed: 18021890
Genes Immun. 2003 Sep;4(6):455-7
pubmed: 12944983
Br J Dermatol. 2000 Nov;143(5):969-73
pubmed: 11069504
Br J Pharmacol. 2017 Sep;174(17):2801-2804
pubmed: 28801996
Curr Top Med Chem. 2017;17(2):174-188
pubmed: 27237331
Drug Dev Res. 2020 Nov;81(7):765-767
pubmed: 32337769
J Invest Dermatol. 2013 Feb;133(2):377-85
pubmed: 23014338
J Am Acad Dermatol. 1995 Jun;32(6):982-6
pubmed: 7751469
Br J Pharmacol. 2015 Jul;172(14):3461-71
pubmed: 26114403
J Invest Dermatol. 2006 Aug;126(8):1784-91
pubmed: 16543895
Clin Rev Allergy Immunol. 2016 Jun;50(3):377-89
pubmed: 27025861
Curr Protoc Immunol. 2013 Nov 18;103:21.4.1-21.4.26
pubmed: 24510546
Recent Pat Anticancer Drug Discov. 2009 Jan;4(1):92-7
pubmed: 19149691
Dermatology. 2019;235(2):91-100
pubmed: 30566935
PLoS One. 2010 Feb 11;5(2):e9165
pubmed: 20161797
Life Sci. 2019 Sep 1;232:116595
pubmed: 31238053
Australas J Dermatol. 2012 Feb;53(1):1-18
pubmed: 22309324
J Control Release. 2013 Aug 28;170(1):51-63
pubmed: 23643662
Clin Exp Dermatol. 2017 Mar;42(2):172-177
pubmed: 28054376
Phytochemistry. 2015 Mar;111:7-13
pubmed: 25583437
Trends Immunol. 2009 Oct;30(10):494-501
pubmed: 19781993
Mediators Inflamm. 2021 Jul 31;2021:8437753
pubmed: 34381307
Appl Immunohistochem Mol Morphol. 2019 Aug;27(7):558-563
pubmed: 29271792
Evid Based Complement Alternat Med. 2021 Nov 29;2021:8402517
pubmed: 34880922
Pharmacol Rep. 2019 Dec;71(6):1228-1234
pubmed: 31670059
Pharmacol Rep. 2021 Feb;73(1):154-162
pubmed: 32166733
J Cutan Med Surg. 2002 Nov-Dec;6(6):554-60
pubmed: 12362256
An Bras Dermatol. 2017 Jul-Aug;92(4):470-473
pubmed: 28954093
Curr Drug Metab. 2013 Mar;14(3):351-60
pubmed: 22935070
Clin Exp Dermatol. 2009 Aug;34(6):658-63
pubmed: 19558584
Int Immunopharmacol. 2019 Dec;77:105923
pubmed: 31711937
Biofactors. 2021 Nov;47(6):975-991
pubmed: 34534373
Evid Based Complement Alternat Med. 2018 Jan 24;2018:7931031
pubmed: 29619073